Cargando…
Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy
Biomarker-driven trials hold promise for therapeutic development in chronic diseases, such as muscular dystrophy. Myotonic dystrophy type 1 (DM1) involves RNA toxicity, where transcripts containing expanded CUG-repeats (CUG(exp)) accumulate in nuclear foci and sequester splicing factors in the Muscl...
Autores principales: | Tanner, Matthew K, Tang, Zhenzhi, Thornton, Charles A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913682/ https://www.ncbi.nlm.nih.gov/pubmed/33503262 http://dx.doi.org/10.1093/nar/gkab022 |
Ejemplares similares
-
Modifications to toxic CUG RNAs induce structural stability, rescue mis-splicing in a myotonic dystrophy cell model and reduce toxicity in a myotonic dystrophy zebrafish model
por: deLorimier, Elaine, et al.
Publicado: (2014) -
Integrative transcriptome sequencing reveals extensive alternative trans-splicing and cis-backsplicing in human cells
por: Chuang, Trees-Juen, et al.
Publicado: (2018) -
Targeting alternative splicing by RNAi: from the differential impact on splice variants to triggering artificial pre-mRNA splicing
por: Fuchs, Armin, et al.
Publicado: (2021) -
Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy
por: Wojtkowiak-Szlachcic, Agnieszka, et al.
Publicado: (2015) -
An engineered RNA binding protein with improved splicing regulation
por: Hale, Melissa A, et al.
Publicado: (2018)